$The utility of quantitative 18F-FDG PET/CT-derived parameters as prognostic factors for predicting overall survival in radioiodine-refractory differentiated thyroid cancer$
QR Code

QR Code

The utility of quantitative 18F-FDG PET/CT-derived parameters as prognostic factors for predicting overall survival in radioiodine-refractory differentiated thyroid cancer

Objective(s): This study investigates the relationship between quantitative 18F-FDG PET/CT metabolic parameters and overall survival (OS) in patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC). Methods: We conducted a prospective analysis of 127 patients with RAI-R DTC. Qu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mai Son, Nguyen Phuong, Le Ha
Format:	Article
Language:	English
Published:	Mashhad University of Medical Sciences 2025-07-01
Series:	Asia Oceania Journal of Nuclear Medicine and Biology
Subjects:	differentiated thyroid cancer radioiodine-refractory 18f-fdg pet/ct, 18f-fdg metabolic parameters overall survival
Online Access:	https://aojnmb.mums.ac.ir/article_25945_73649a5fe52455f6056b1b510aaf5400.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparing the diagnostic efficacy of [18F]FDG PET/CT and [18F]FDG PET/MRI in breast cancer recurrence: a systematic review and meta-analysis
by: Shiqing Liu, et al.
Published: (2025-08-01)

Patient dose reduction by changing the amount of 18F-FDG radiopharmaceutical injected
by: Fernanda Guerra Paiva, et al.
Published: (2019-02-01)

Primary Mediastinal B-Cell Lymphoma and [18F]FDG PET/CT: What We Learned and What Is New
by: Anna Giulia Nappi, et al.
Published: (2025-04-01)

[18F]-Fluoroestradiol PET/CT: a modern look at nuclear medicine applications
by: A. V. Parnas, et al.
Published: (2021-06-01)

<sup>18</sup>F-FDG PET/CT in the Diagnosis of Cervical Cancer
by: A. V. Leontyev, et al.
Published: (2022-12-01)

Complex Immunotherapy-mediated Response Patterns Depicted on Serial 18F-FDG PET imaging of Hodgkin Lymphoma Patient Undergoing Pembrolizumab Therapy
by: Mohanad Badarneh, et al.
Published: (2025-07-01)

The application of PET/CT with 18F-FDG in the differential diagnosis of lung solitary lesions
by: G. V. Afonin, et al.
Published: (2022-09-01)

Diagnostic Utility of <sup>18</sup>F-FDG PET/CT in Infective Endocarditis
by: Corina-Ioana Anton, et al.
Published: (2025-06-01)

DETECTION OF EXTRANODAL INVOLVEMENT IN PATIENTS WITH LYMPHOMAS USING THE COMBINED PET-CT
by: А. V. Vazhenin, et al.
Published: (2016-02-01)

Comparison of [18F]AlF-NOTA-FAPI-04 PET/CT and [18F]FDG PET/CT for diagnosing lymph node metastasis in malignant tumors
by: Wanjing Zhou, et al.
Published: (2025-07-01)

Utility of 18F-FDG PET/CT and Cardiac MRI in early Cardiac Sarcoidosis
by: Muthiah Subramanian, et al.
Published: (2025-07-01)

Diagnostic value of dual-tracer PET/CT with [18F]FDG and PSMA ligands in prostate cancer: an updated systematic review
by: Cesare Michele Iacovitti, et al.
Published: (2025-07-01)

Estimation of dose distribution in occupationally exposed individuals to FDG-18F
by: Isabelle Viviane Batista de Lacerda, et al.
Published: (2015-05-01)

Prognostic Value of Multiple Manual Segmentation Methods for Diffuse Large B-Cell Lymphoma with <sup>18</sup>F-FDG PET/CT
by: Andrej Doma, et al.
Published: (2025-06-01)

18F-FDG PET/CT Impact on Malignant Melanoma Patients Undergoing Staging and Restaging: A Single-University-Center Experience in a Real-World Setting
by: Silvija Lucic, et al.
Published: (2025-06-01)

IPET-CT in inflammatory diseases of kidneys and bladder: diagnostic efficacy
by: V. B. Berdichevsky, et al.
Published: (2021-12-01)

Prognostic value of a simple distance index derived from PET maximum intensity projection
by: Isaac Kargar Samani, et al.
Published: (2025-07-01)

[18F]FMISO PET in metastatic neuroendocrine tumours: a pilot study
by: David Chan, et al.
Published: (2025-07-01)

The Combined Prognostic Value of 18F‐FDG PET/CT Metabolic Parameters of Immune Organs and Hematological Immune‐Related Markers in Patients With Locally Advanced Cervical Cancer
by: Yi Li, et al.
Published: (2025-02-01)

The Role of [18F]FDG PET Imaging for the Assessment of Pulmonary Lymphangitic Carcinomatosis: A Comprehensive Narrative Literature Review
by: Francesco Dondi, et al.
Published: (2025-06-01)

Atypical Uptake of 18<sup>F</sup>DG in White Adipose Tissue During PET/CT in Children
by: M. M. Dunaikin, et al.
Published: (2023-08-01)

18FDG PET/CT is sensitive but not specific for malignancy: two cases of disseminated tuberculosis mimicking metastatic cancer on imaging and clinical presentation
by: Maxime Collin, et al.
Published: (2025-06-01)

Mild SARS-CoV-2 Infection with the Omicron Variant Mimicking Metastatic Cancer on Whole-Body 18-F FDG PET/CT Imaging
by: Gunnhild Helmsdal, et al.
Published: (2025-06-01)

The research on the association between genetic alterations of DLBCLs and 18F-FDG PET/CT SUVmax and their clinical significance
by: TIAN Tian, CHEN Chen, WEI Ran, BAO Longlong, GU Bingxin, ZHANG Qunling, CAO Junning, YU Baohua, LI Xiaoqiu, ZHOU Xiaoyan
Published: (2025-06-01)

Predictive value of initial involvement and early response assessment using positron‑emission tomography with 18F‑FLT in patients with non‑Hodgkin lymphoma
by: Yu. N. Likar, et al.
Published: (2014-07-01)

Dosimetric evaluation of extremities in 18F-FDG PET/CT procedure using Monte Carlo Geant4 code
by: Paula Rocha Pessanha, et al.
Published: (2019-10-01)

Assessment of the particular demand for 18FDG/PET-CT procedures: a discussion regarding new incorporations by the SUS
by: Adriana de Souza Medeiros Batista, et al.
Published: (2022-12-01)

Radiologic Predictors of Disease Recurrence in Nasopharyngeal Carcinoma: A Retrospective Evaluation of MRI and <sup>18</sup>F-FDG-PET/CT Parameters
by: Banu Karaalioğlu, et al.
Published: (2025-06-01)

Total Lesion Glycolysis (TLG) on 18F-FDG PET/CT as a Potential Predictor of Pathological Complete Response in Locally Advanced Rectal Cancer After Total Neoadjuvant Therapy: A Retrospective Study
by: Handan Tokmak, et al.
Published: (2025-07-01)

A CASE REPORT OF HIGH 18FFDG UPTAKE IN LEIOMYOMA OF THE ESOPHAGUS AND STOMACH
by: A. S. Subbotin, et al.
Published: (2016-12-01)

Variability of Metabolic Rate and Distribution Volume Quantification in Whole-Body Parametric PATLAK [<sup>18</sup>F]-FDG PET/CT—A Prospective Trial in Patients with Lung Cancer
by: Stephan Ursprung, et al.
Published: (2025-07-01)

A case of invasive lobular carcinoma, highlighting the emerging role of 18F-Fluoroestradiol PET
by: Michael Wallace, MMS, MS, et al.
Published: (2025-10-01)

Dedifferentiated liposarcoma lung metastases with different FDG-PET/CT findings
by: Yoshito Imamura, et al.
Published: (2023-05-01)

The significance of cardiac inflammatory protocol of FDG PET-CT in the diagnosis and response assessment of tuberculous pericarditis: A case report
by: Kabilash Dhayalan, et al.
Published: (2025-07-01)

Development of alternative methodology for normalization of the small animals PET scanner of LIM/CDTN
by: Anna Clara Moreira da Silva, et al.
Published: (2024-02-01)

[18F]FDG/PET: a non-invasive technique for the study of stroke in murine and rat models
by: B. G. A. Schirmer, et al.
Published: (2023-04-01)

Value of [<sup>18</sup>F]FDG PET/CT for predicting epidermal growth factor receptor gene mutation status in patients with newly diagnosed non-small cell lung cancer: a retrospective single center study
by: A. V. Leontev, et al.
Published: (2025-06-01)

18F-FDG PET and combined diffusion weighted MRI features in pleural infection: A case report
by: KyungAh Chun, MD, PhD
Published: (2025-09-01)

Monitoring internal contamination from OEW of an 18F-FDG production plant: WBC or head counting setup?
by: Bruno Melo Mendes, et al.
Published: (2019-07-01)

POSITRON EMISION TOMOGRAPHY FOR DETECTION OF DISTANT METASTASES IN PATIENTS WITH BREAST CANCER
by: N. G. Chanchikova, et al.
Published: (2020-03-01)